Interview with Dr. Martin Blaser of Rutgers University

NY data shows the vaccine’s ability to prevent infections in young children drops to 12% after about a month

But that could take a while, Dr. Anthony Fauci’s still banking on the current booster

The lab is sequencing every positive test it gets, expecting to find omicron soon.

Interview with Dr. Martin Blaser, professor of medicine and infectious diseases at Rutgers University

Immune response was boosted in transplant patients who got a third shot of vaccine

State will deploy the so-called triplets, three public health vans designed to host vaccination clinics in neighborhoods

Thirty COVID-19 cases caused by this coronavirus variant have been identified in NJ

A lingering lack of confidence in Johnson and Johnson's COVID-19 vaccine remains following its 10-day suspension over a rare, but serious, blood clotting problem.

Health officials say vaccinations are helping to ward off infectious coronavirus variants but getting to herd immunity will still be a challenge

Will an annual vaccination be necessary?

Vaccines that have already been distributed were not affected. Briana Vannozzi spoke to Dr. Martin Blaser about the mixup and what it means for vaccine ...

The concept of herd immunity is reached when enough people in a community have either been infected with the virus or vaccinated against it. Rutgers ...

Critics are concerned about creating two classes of citizens

Molnupiravir works to stop the COVID-19 virus from replicating itself. Fewer viruses in your body mean a faster recovery and lower transmission rate.

Flu cases are at an all time low, likely due to COVID-19 precautions

Concern over relative vaccine efficacy has prompted patients' demands

Johnson & Johnson now expected to ship only ‘a few million’ doses initially

A look at the vaccines currently in use, those for which approval is being sought, and others still in trials

The company is promising 100 million doses for the U.S. by the end of June